9 January 2018 - Yes, overall spending on prescription drugs has slowed recently, but expect Democrats to pummel Alex Azar over sky-high prices of specialty and cutting-edge medications as he testifies before a Senate panel this morning.

If Azar is confirmed -- and it's likely he will be -- he would be HHS's first secretary with a background in the pharmaceutical industry.

On that note, we thought it would be timely to look at 10 of the new drugs expected to rack up the most money as they hit the market this year (although none of them are Lilly products.) The following list is from the London-based firm EvaluatePharma, and the drugs are ranked according to projected U.S. sales in 2022.

Read Washington Post article